Join us on today's episode as we explore AJNA BioSciences' mission to bring FDA-approved botanical drugs to the market, revolutionizing medicine. CEO Joel Stanley highlights the importance of FDA approval for safe and effective treatment options, aiming to make botanical drugs a standard part of patient care. With a dedicated research team and the opportunity for investors to support this vision, AJNA is poised to change the healthcare paradigm.